Dr. May on Olaratumab Activity in Pediatric Bone and Soft Tissue Sarcoma
4 Görünümler
• 07/18/23
0
0
gömmek
administrator
Aboneler
Caitlin May, PhD, postdoctoral research fellowship at Eli Lilly and Company, discusses olaratumab's (Lartruvo) demonstrating anti-tumor activity in models of pediatric bone and soft-tissue sarcoma.
Daha fazla göster
Facebook Yorumları
SORT BY-
En Çok Yorumlananlar
-
Son Yorumlar